Table 2 Treatment setting and dosing regimen
Drug | n | Manufacturer | Trial | Dose received | Schedule |
|---|---|---|---|---|---|
Sunitinib | 10 | Pfizer | NA | 50 mg od | 28d on/14d off |
Sunitinib | 3 | Pfizer | COMPARZ (NCT00720941) | 50 mg od | 28d on/14d off |
Sunitinib | 1 | Pfizer | TRIST (NCT00397345) | 50 mg od | 28d on/14d off |
Pazopanib | 5 | GlaxoSmithKline | COMPARZ (NCT00720941) | 800 mg od | Continuous |
Cediranib | 2 | Astra Zeneca | D8480C00030 (NCT00423332) | 45 mg od | Continuous |
Regorafenib | 2 | Bayer Healthcare Pharmaceuticals | DAST (NCT00664326) | 160 mg od | 21d on/7d off |
